GRAZIANI, TIZIANO
GRAZIANI, TIZIANO
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy.
2019 Ceci F, Castellucci P, Graziani T, Farolfi A, Fonti C, Lodi F, Fanti S.
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy.
2018 Farolfi A, Ceci F, Castellucci P, Graziani T, Siepe G, Lambertini A, Schiavina R, Lodi F, Morganti AG, Fanti S
Incidental detection of basaloid thymic carcinoma with 68 Ga-PSMA-11 PET/CT in recurrent prostate cancer patient
2018 Farolfi, A.; Ceci, F.; Graziani, T.; Lambertini, A.; Cervati, V.; Basilico, G.L.; Biraghi, T.; Briganti, A.; Castellucci, P.; Fanti, S.
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis
2018 Ghedini, Pietro*; Bossert, I.; Zanoni, L.; Ceci, F.; Graziani, T.; Castellucci, P.; Ambrosini, V.; Massari, F.; Nobili, E.; Melotti, B.; Musto, A.; Zoboli, S.; Antunovic, L.; Kirienko, M.; Chiti, A.; Mosconi, C.; Ardizzoni, A.; Golfieri, R.; Fanti, S.; Nanni, C.
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence.
2017 Angelini A, Ceci F, Castellucci P, Graziani T, Polverari G, Trovarelli G, Palmerini E, Ferrari S, Fanti S, Ruggieri P.
11C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series
2016 Graziani, Tiziano; Ceci, Francesco; Castellucci, Paolo; Polverari, Giulia; Lima, Giacomo Maria; Lodi, Filippo; Morganti, Alessio Giuseppe; Ardizzoni, Andrea; Schiavina, Riccardo; Fanti, Stefano
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel
2016 Ceci, F; Castellucci, P; Graziani, T; Schiavina, R; Renzi, R; Borghesi, M; Di Tullio, P; Brunocilla, E; Ardizzoni, A; Fanti, S
Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients
2016 P Ghedini, I Bossert, T Graziani, F Ceci, F Massari, E Nobili, B Melotti, P Castellucci, S Fanti, C Nanni
Ga-68-PSMA PET/CT for early restaging prostate cancer. Preliminary results of a prospective trial in patients with biochemical failure after radical therapy and PSA levels< 2 ng/mL
2016 francesco ceci; castellucci paolo; tiziano graziani; cristina fonti; filippo lodi; stefano boschi; stefano fanti
PET imaging in prostate cancer, state of the art: a review of 18F-choline and 11C-choline PET/CT applications
2016 Castellucci, Paolo*; Ceci, Francesco; Graziani, Tiziano; Fanti, Stefano
PET/CT and prostate cancer
2016 Ceci, Francesco*; Castelluci, Paolo; Graziani, Tiziano
Response Evaluation to Radium-223-Dichloride in Castration-Resistant Metastatic Prostate Cancer using 11C-choline PET/CT and Bone Scintigraphy
2016 P Ghedini, T Graziani, E Lodi Rizzini, GM Lima, A Matti, I Bossert, F Ceci, GC Montini, F Monari, A Morganti, P Castellucci, S Fanti
11C-Choline PET/CT and Bladder Cancer: Lymph Node Metastasis Assessment With Pathological Specimens as Reference Standard
2015 Ceci F; Bianchi L; Graziani T; Castellucci P; Pultrone C; Eugenio B; Martorana G; Colletti PM; Rubello D; Fanti S; Schiavina R
11C-Choline PET/CT Identifies Osteoblastic and Osteolytic Lesions in Patients with Metastatic Prostate Cancer.
2015 Ceci F; Castellucci P; Graziani T; Schiavina R; Chondrogiannis S; Bonfiglioli R; Costa S; Virgolini IJ; Rubello D; Fanti S; Colletti PM
PET/Computed Tomography in the Individualization of Treatment of Prostate Cancer.
2015 Ceci, F; Castellucci, P; Graziani, T; Schiavina, R; Fanti, S
PET/CT in prostate cancer
2015 Castellucci, P.*; Ceci, F.; Graziani, T.; Juarez, A.R.; Alvarez Nieto, L.F.; Fanti, S.
Clinical impact of 11C-Choline PET/CT in recurrent prostate cancer patients after radical therapy: Which is the real impact on treatment decisions?
2014 Francesco Ceci, Ken Herrmann, Paolo Castellucci, Tiziano Graziani, Christina Bluemel, Joshua James Morigi, Riccardo Schiavina, Vollmer Christian, Andreas Buck, Stefano Fanti
Erratum to: Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial.
2014 Ceci F; Herrmann K; Castellucci P; Graziani T; Bluemel C; Schiavina R; Vollmer C; Droll S; Brunocilla E; Mazzarotto R; Buck AK; Fanti S
Role of 11C-Choline PET/CT in androgen sensitive prostate cancer patients treated with intermittent ADT: A sequential PET/CT study after therapy interruption
2013 Francesco Ceci, Paolo Castellucci, Chiara Fuccio, Riccardo Schiavina, Joshua James Morigi, Tiziano Graziani, Daniele Romagnoli, Filippo Lodi, Stefano Fanti